PharmaCyte Biotech, Inc. (NASDAQ:PMCB) Financings

PharmaCyte Biotech, Inc.

Financings

RaiseDate
Private placement of series C convertible preferred stock and common stock purchase warrants
Closed: US$7M raised · US$1,000 a share · Warrants at US$1 for 60 months · GP Nurmenkari Inc.
Dealers: GP Nurmenkari Inc. (lead)
Use of proceeds: Strengthen balance sheet to support ongoing business initiatives and strategic growth opportunities
Aug 20, 2025

Read by 6ix AI from the company's releases